Mohammed Alshalalfa
Mohammed Alshalalfa
Bioinformatician and Genomic Analyst
Verified email at
Cited by
Cited by
Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy
SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ...
JAMA oncology 3 (12), 1663-1672, 2017
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ...
The lancet oncology 17 (11), 1612-1620, 2016
Efficient periodicity mining in time series databases using suffix trees
F Rasheed, M Alshalalfa, R Alhajj
IEEE Transactions on Knowledge and Data Engineering 23 (1), 79-94, 2010
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes
SA Tomlins, M Alshalalfa, E Davicioni, N Erho, K Yousefi, S Zhao, ...
European urology 68 (4), 555-567, 2015
The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer
JR Prensner, A Sahu, MK Iyer, R Malik, B Chandler, IA Asangani, ...
Oncotarget 5 (6), 1434, 2014
Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome
S You, BS Knudsen, N Erho, M Alshalalfa, M Takhar, HA Ashab, ...
Cancer research 76 (17), 4948-4958, 2016
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ...
Oncotarget 7 (33), 53362, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B Benzon, SG Zhao, MC Haffner, M Takhar, N Erho, K Yousefi, P Hurley, ...
Prostate cancer and prostatic diseases 20 (1), 28-35, 2017
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
A Urbanucci, SJ Barfeld, V Kytölä, HM Itkonen, IM Coleman, D Vodák, ...
Cell reports 19 (10), 2045-2059, 2017
Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer
L Yang, D Roberts, M Takhar, N Erho, BAS Bibby, N Thiruthaneeswaran, ...
EBioMedicine 31, 182-189, 2018
Racial variations in prostate cancer molecular subtypes and androgen receptor signaling reflect anatomic tumor location
FA Faisal, D Sundi, JJ Tosoian, V Choeurng, M Alshalalfa, AE Ross, ...
European urology 70 (1), 14-17, 2016
TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup
DP Labbé, CJ Sweeney, M Brown, P Galbo, S Rosario, KM Wadosky, ...
Clinical Cancer Research 23 (22), 7072-7083, 2017
Clinical and genomic characterization of low–prostate-specific antigen, high-grade prostate cancer
BA Mahal, DD Yang, NQ Wang, M Alshalalfa, E Davicioni, V Choeurng, ...
European urology 74 (2), 146-154, 2018
Application of a clinical whole-transcriptome assay for staging and prognosis of prostate cancer diagnosed in needle core biopsy specimens
BS Knudsen, HL Kim, N Erho, H Shin, M Alshalalfa, LLC Lam, I Tenggara, ...
The Journal of Molecular Diagnostics 18 (3), 395-406, 2016
Multi-institutional analysis shows that low PCAT-14 expression associates with poor outcomes in prostate cancer
NM White, SG Zhao, J Zhang, EB Rozycki, HX Dang, SD McFadden, ...
European urology 71 (2), 257-266, 2017
Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer
AP Mitra, LL Lam, M Ghadessi, N Erho, IA Vergara, M Alshalalfa, C Buerki, ...
JNCI: Journal of the National Cancer Institute 106 (11), 2014
Cyclin D1 loss distinguishes prostatic small-cell carcinoma from most prostatic adenocarcinomas
H Tsai, CL Morais, M Alshalalfa, HL Tan, Z Haddad, J Hicks, N Gupta, ...
Clinical Cancer Research 21 (24), 5619-5629, 2015
Molecular characterization of neuroendocrine-like bladder cancer
JB Da Costa, EA Gibb, TJ Bivalacqua, Y Liu, HZ Oo, DT Miyamoto, ...
Clinical cancer research 25 (13), 3908-3920, 2019
The DNA methylation landscape of advanced prostate cancer
SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ...
Nature genetics 52 (8), 778-789, 2020
The diverse genomic landscape of clinically low-risk prostate cancer
MR Cooperberg, N Erho, JM Chan, FY Feng, N Fishbane, SG Zhao, ...
European urology 74 (4), 444-452, 2018
The system can't perform the operation now. Try again later.
Articles 1–20